Prostate Cancer Clinical Trial

Genetic Evaluation of Men (GEM)

Summary

This is a prospective research registry and prospective genetic testing cohort study. The goal is to collect personal medical and cancer history data, family cancer data, exposure history, and biospecimens to support research focused on optimal genetic testing strategies for men with prostate cancer with the ultimate goal of informing national guidelines focused on genetic evaluation for prostate cancer.

View Full Description

Full Description

Objectives:

Collect detailed family cancer histories, personal medical history, prostate cancer clinical features, and exposure history from men with prostate cancer and men without prostate cancer to support studies focused on identifying hereditary cancer syndromes and genetic/epidemiologic factors predisposing to prostate cancer susceptibility.
Collect behavioral measures to support research focused on assessing the needs of men undergoing cancer risk evaluation and satisfaction with the process.
Create and maintain a biospecimen bank with specimens from men with prostate cancer and without prostate cancer to support studies focused on genetic alterations predisposing to prostate cancer risk.
Perform targeted and broad-scale genetic and genomic sequencing to detect genetic alterations related to prostate cancer risk.
Develop mechanisms to recontact participants with updates on research genetic results to guide genetic testing for inherited prostate cancer risk.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Men with a personal history of prostate cancer
Unaffected males who are at higher risk for prostate cancer

Exclusion Criteria:

Age < 18 years
Mental or cognitive impairment that interferes with ability to provide informed consent
Social circumstances that may impair the ability to follow through with study or provide informed consent (such as homelessness, drug/alcohol dependence, etc.)

Study is for people with:

Prostate Cancer

Estimated Enrollment:

595

Study ID:

NCT03076242

Recruitment Status:

Active, not recruiting

Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Abington Memorial Hospital
Abington Pennsylvania, 19001, United States
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

595

Study ID:

NCT03076242

Recruitment Status:

Active, not recruiting

Sponsor:


Sidney Kimmel Cancer Center at Thomas Jefferson University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.